Elsevier gets FDA backing for ‘predictive toxicology’ projectMedical publisher Elsevier is working on an algorithm that it hopes will spot the potential for liver toxicity Share XElsevier gets FDA backing for ‘predictive toxicology’ projecthttps://pharmaphorum.com/news/elsevier-gets-fda-backing-for-predictive-toxicology-project/
FDA approves Alnylam’s second RNAi drug – with $442K annual price tagAlnylam has had a second RNA interference (RNAi) drug approved by the FDA, to treat the ultra-rare disease Share XFDA approves Alnylam’s second RNAi drug – with $442K annual price taghttps://pharmaphorum.com/news/fda-approved-alnylams-second-rnai-drug/
FDA approves latest Humira near-copy, as dozens of biosimilars head for marketThe FDA has approved Pfizer’s biosimilar of AbbVie’s blockbuster Humira (adalimumab), meaning that there are now five of Share XFDA approves latest Humira near-copy, as dozens of biosimilars head for markethttps://pharmaphorum.com/news/fda-approves-latest-humira-near-copy-as-dozens-of-biosimilars-head-for-market/
Amarin gets FDA panel okay for new Vascepa indicationAmarin is on course to significantly increase the number of patients eligible for treatment with its purified fish Share XAmarin gets FDA panel okay for new Vascepa indicationhttps://pharmaphorum.com/news/amarin-gets-fda-panel-okay-for-new-vascepa-indication/
FDA tags F2G’s olorofim as Breakthrough Therapy for fungal infectionsThe US drugs regulator has tagged F2G’s olorofim as a potential Breakthrough Therapy for life-threatening fungal infections, pledging Share XFDA tags F2G’s olorofim as Breakthrough Therapy for fungal infectionshttps://pharmaphorum.com/news/fda-tags-f2gs-olorofilm-as-breakthrough-therapy-for-mould-infections/
Stephen Hahn nominated as next FDA CommissionerStephen Hahn has been formally nominated by President Trump as the next FDA Commissioner, as acting chief Ned Share XStephen Hahn nominated as next FDA Commissionerhttps://pharmaphorum.com/news/stephen-hahn-nominated-as-next-fda-commissioner/
Vertex gets early okay for cystic fibrosis triple Trikafta in USVertex Pharma has claimed an ultra-fast approval in the US for Trikafta, its three-drug combination that provides a Share XVertex gets early okay for cystic fibrosis triple Trikafta in UShttps://pharmaphorum.com/news/vertex-gets-early-okay-for-cystic-fibrosis-triple-trikafta-in-us/
Clinuvel gets approval in US for rare skin disorder drug ScenesseAustralian biotech Clinuvel has claimed a US approval for Scenesse, a treatment for a rare skin disorder that Share XClinuvel gets approval in US for rare skin disorder drug Scenessehttps://pharmaphorum.com/news/clinuvel-gets-approval-in-us-for-rare-skin-disorder-drug-scenesse/
Trump’s pick for next FDA chief is MD Anderson’s Stephen Hahn; reportsPresident Donald Trump plans to nominate leading oncologist Stephen Hahn as the new FDA commissioner, according to multiple Share XTrump’s pick for next FDA chief is MD Anderson’s Stephen Hahn; reportshttps://pharmaphorum.com/news/trumps-pick-for-next-fda-chief-is-cancer-specialist-stephen-hahn-reports/
